Suven Life Sciences Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Suven Life Sciences Ltd.
India had a busy deals calendar in 2022, with companies led by Biocon striking large M&A deals while PE activity declined. In Vivo's sister publication Scrip pieced together data for infographics on these deals. A multitude of factors is expected to keep the momentum going in 2023.
India had a busy deals calendar in 2022, with companies led by Biocon striking large M&A deals while PE activity declined. Scrip pieced together data for infographics on these deals. A multitude of factors is expected to keep the momentum going in 2023
The firms unveiled positive Phase III data from their respective assets for treating the agitation seen in Alzheimer’s disease with Lundbeck’s candidate set to become first-to-market for the challenging behavioral symptom.
Complaint filed in Maryland federal court says Australian firm, which received more than $230 from US government to boost production of its OTC COVID-19 diagnostic tests available to US consumers, should’ve offered refunds to consumers who bought tests the company has recalled due to false positive tests.
- In Vitro Diagnostics
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Drug Delivery
- Drug Discovery Tools
Drug Discovery Tools
- Molecular Diversity
- Other Names / Subsidiaries
- SUVEN LIFE Sciences Limited
- Suven Neurosciences Inc
- Suven Inc
- SUVEN PHARMACEUTICALS LIMITED
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.